Precision Neuroscience is a biotechnology company which offers brain–computer interface technology to patients with neurological conditions. Their flagship product, the Layer 7 Cortical Interface, is designed to conform to the brain's surface without damaging tissue, striving to enable high-resolution neural recording. Precision Neuroscience aims to connect human and artificial intelligence by developing minimally invasive neural implants that seek to translate brain signals into digital commands. The company was founded by Benjamin Rapoport and Michael Mager in 2021 and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/16/2024 | Series C | $102MM | $xx.xx | $542.69MM | B Capital, Duquesne Family Office, General Equity Holdings, Steadview Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,894,737
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital, Duquesne Family Office, General Equity Holdings, Steadview Capital
|
||||||
03/26/2024 | Series C-1 | $27.5MM | $xx.xx | $542.69MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,360,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/25/2023 | Series B | $41.15MM | $xx.xx | $163.91MM | Alumni Ventures, B Capital Group, Draper Associates, Forepont Capital Partners, Mubadala Capital, Re.Mind Capital, Steadview Capital | |
Price per Share
$xx.xx
Shares Outstanding
16,835,784
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alumni Ventures, B Capital Group, Draper Associates, Forepont Capital Partners, Mubadala Capital, Re.Mind Capital, Steadview Capital
|
||||||
05/25/2021 | Series A | $12MM | $xx.xx | $36.36MM | B Capital Group, Steadview Capital | |
Price per Share
$xx.xx
Shares Outstanding
11,999,995
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Steadview Capital
|